IC
EW icon

Intersect Capital’s Edwards Lifesciences EW Stock Holding History

Intersect Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,351
Closed -$512K – 374
2022
Q1 		$512K Buy
4,351
+288
+7% +$32.3K 0.1% 190
2021
Q4 		$526K Sell
4,063
-386
-9% -$45K 0.1% 190
2021
Q3 		$504K Buy
4,449
+137
+3% +$15.6K 0.09% 187
2021
Q2 		$447K Buy
4,312
+214
+5% +$20.2K 0.08% 195
2021
Q1 		$343K Sell
4,098
-164
-4% -$13.9K 0.07% 221
2020
Q4 		$389K Sell
4,262
-209
-5% -$17.3K 0.09% 176
2020
Q3 		$357K Buy
+4,471
New +$349K 0.1% 154

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intersect Capital's EW Position: Q2 2022 in Review

Intersect Capital sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 4,351 shares — an estimated $512K sold.

Intersect Capital first reported a position in EW in Q3 2020 and held it in 7 quarters. The position peaked at $526K in Q4 2021. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Intersect Capital reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Intersect Capital sold 4,351 Edwards Lifesciences shares in Q2 2022, an estimated $512K.
  • Intersect Capital first reported a position in Edwards Lifesciences in Q3 2020 and held it in 7 quarters.
  • Intersect Capital's Edwards Lifesciences position peaked at $526K in Q4 2021.
  • 1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.